Importance of Tissue Selection for Genetic Testing: Detection of a Terminal 18q Deletion after Stem Cell Transplantation

Fördermittel

Funding Sources and Conflict of Interest : CG received academic research support from the VolkswagenStiftung (Freigeist Fellowship). The authors declare that there are no conflicts of interest relevant to this work. Financial Disclosures for the Previous 12 Months: T.M. receives royalties from Urban Fischer in Elsevier Verlag and honoraria for lectures from GE Healthcare. T.M. is a participant in the Berlin Institute of Health–Charité Clinician Scientist Program funded by the Charité‐Universitätsmedizin Berlin and the Berlin Institute of Health. S.B. reports no disclosures. C.K. serves as a medical advisor to Centogene for genetic testing reports on movement disorders and dementia excluding Parkinson's disease. A.A.K. is a consultant to Boston Scientific and has received honoraria for speaking from Medtronic, Boston Scientific, and Abbott and grants from Medtronic, all outside the submitted work. K.L. receives funding from the German Research Foundation (FOR2488), the Federal Ministry of Education and Sciences, the Movement Disorder Society, and the Damp‐Foundation. C.G. holds research grants from the VolkswagenStiftung (Freigeist Fellowship) and the German Parkinson Society and was also supported by the Deutsche Forschungsgemeinschaft (GA2031/1‐1 and GA2031/1‐2).